Retinitis Pigmentosa in Ghana: A Practical Guide for Patients and Families

If you or someone in your family has been told you might have Retinitis Pigmentosa (RP), the first thing to know is that it's a manageable, well-studied condition — even though it's not yet curable. This guide walks through what's actually happening inside the eye, how doctors in Ghana confirm the diagnosis, and what steps genuinely make a difference, so you can separate real medical guidance from exaggerated treatment claims.

Understanding the Condition

RP is an inherited group of retinal disorders in which the photoreceptor cells — rods first, then often cones — gradually stop functioning and die off. Because rods handle night vision and the edges of your visual field, the earliest sign is almost always trouble seeing in low light, long before central vision is affected. The rate of decline differs enormously between individuals, even siblings with the same diagnosis.

Signs to Watch For

Genetics: Why It Runs in Families

More than 80 genes have been linked to RP, and the way it's inherited — dominant, recessive, or X-linked — depends on which one is involved. In Ghana, where consanguineous marriage patterns exist in some communities, recessive forms of RP can appear even without an obvious family history, since both parents may silently carry the same gene. This is one reason genetic counselling is valuable even when no relative has ever been diagnosed.

Getting a Proper Diagnosis

A standard vision test at a pharmacy or optical shop cannot diagnose RP. You need a dilated retinal exam by an ophthalmologist, ideally followed by:

• Electroretinography (ERG) to measure how the retina responds electrically to light
• Visual field testing to chart the extent of vision loss
• OCT imaging to assess the health of remaining retinal layers
• Genetic testing, where accessible, to identify the specific gene involved

Korle Bu Teaching Hospital and other tertiary eye units are typical referral points in Ghana for this level of testing; a general practitioner or optician should refer onward rather than attempt to manage RP directly.

Separating Real Treatment From Overpromising Claims

There is no cure for RP today. Approach any advertisement promising stem cell injections will restore your sight with real skepticism — this claim is not backed by mainstream, peer-reviewed clinical trial evidence, and pursuing it can mean significant cost for no proven benefit. What is actually supported by evidence:

• Gene therapy (Luxturna) — approved only for RP caused by confirmed biallelic RPE65 mutations, identified through genetic testing.
• Vitamin A palmitate — modest evidence of slowing progression in some adult RP patients, but only under medical supervision due to toxicity risk at high doses.
• Low-vision rehabilitation — training and devices that help you use remaining vision as effectively as possible.
• Cataract and complication management — RP patients often develop cataracts earlier; treating these can meaningfully improve remaining vision.
• Ongoing monitoring — regular check-ups track progression and catch treatable issues.